文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

COVID-19患者循环性激素与炎症及疾病严重程度的关联

Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.
PubMed 文献 · JAMA Netw Open · 2021-05-03
一句话结论在男性COVID-19患者中,住院期间较低的睾酮浓度与疾病严重程度增加和炎症相关。

这项前瞻性队列研究纳入2020年3月至5月在Barnes Jewish Hospital连续就诊的152例COVID-19患者,检测血清睾酮、雌二醇和IGF-1浓度。在男性中,重症患者第0天和第3天睾酮浓度低于轻症患者,且睾酮与IL-6、CRP、IL-1RA、HGF和IP-10呈负相关。雌二醇和IGF-1在男性中与严重程度无关,女性中三种激素均与严重程度无关。对单核细胞的RNA测序显示,需要ICU治疗的男性患者激素信号通路上调,但该通路与血清激素浓度不平行。

要点

  • 在66例重症男性COVID-19患者中,第0天中位睾酮浓度为53(18-114)ng/dL,低于24例轻症男性的151(95-217)ng/dL(P=0.01)。
  • 重症男性患者第3天中位睾酮浓度为19(6-68)ng/dL,低于轻症男性的111(49-274)ng/dL(P=0.006)。
  • 男性睾酮浓度与IL-6(β=-0.43;95%CI,-0.52至-0.17;P<0.001)、CRP(β=-0.38;95%CI,-0.78至-0.16;P=0.004)、IL-1RA(β=-0.29;95%CI,-0.64至-0.06;P=0.02)、HGF(β=-0.46;95%CI,-0.69至-0.25;P<0.001)和IP-10(β=-0.32;95%CI,-0.62至-0.10;
  • 男性雌二醇和IGF-1浓度与COVID-19严重程度无关;女性中睾酮、雌二醇和IGF-1浓度在重症与非重症间相似。
  • 在需要ICU治疗的男性COVID-19患者中,经典单核细胞(CD14+CD16-)和非经典单核细胞(CD14-CD16+)的激素信号通路上调;单核细胞激素信号通路与血清激素浓度不平行。

适用人群与场景

  • 2020年3月至5月在密苏里州圣路易斯Barnes Jewish Hospital连续就诊的COVID-19患者(经鼻咽拭子诊断)。
  • 共152例患者(90例[59.2%]男性;62例[40.8%]女性;平均[SD]年龄63[16]岁),其中143例(94.1%)住院。

研究设计与关键结果

  • 研究类型:前瞻性队列研究,单中心,纳入152例COVID-19患者。
  • 在66例重症男性患者中,第0天中位(四分位距)睾酮浓度为53(18-114)ng/dL,而24例轻症男性为151(95-217)ng/dL(P=0.01)。
  • 在66例重症男性患者中,第3天中位(四分位距)睾酮浓度为19(6-68)ng/dL,而24例轻症男性为111(49-274)ng/dL(P=0.006)。
  • 男性睾酮浓度与IL-6(β=-0.43;95%CI,-0.52至-0.17;P<0.001)、CRP(β=-0.38;95%CI,-0.78至-0.16;P=0.004)、IL-1RA(β=-0.29;95%CI,-0.64至-0.06;P=0.02)、HGF(β=-0.46;95%CI,-0.69至-0.25;P<0.001)和IP-10(β=-0.32;95%CI,-0.62至-0.10;P=0.007)呈负相关。
  • 男性雌二醇和IGF-1浓度与COVID-19严重程度无关;女性中睾酮、雌二醇和IGF-1浓度在重症与非重症间相似。
  • 基因集富集分析显示,在需要ICU治疗的男性COVID-19患者中,经典单核细胞(CD14+CD16-)和非经典单核细胞(CD14-CD16+)的激素信号通路上调。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:单中心队列研究;激素信号通路在单核细胞中与血清激素浓度不平行;需要进一步研究以了解其与COVID-19的病理生理关联。

对床旁实践的改变

  • 在男性COVID-19患者中,住院期间较低的睾酮浓度与疾病严重程度增加和炎症相关。
  • 激素信号通路在单核细胞中与血清激素浓度不平行;作者认为需要进一步研究以了解其与COVID-19的病理生理关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Male sex is a risk factor for developing severe COVID-19 illness. It is not known whether sex hormones contribute to this predisposition.

OBJECTIVE: To investigate the association of concentrations of serum testosterone, estradiol, and insulinlike growth factor 1 (IGF-1, concentrations of which are regulated by sex hormone signaling) with COVID-19 severity.

DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted using serum samples collected from consecutive patients who presented from March through May 2020 to the Barnes Jewish Hospital in St Louis, Missouri, with COVID-19 (diagnosed using nasopharyngeal swabs).

EXPOSURES: Testosterone, estradiol, and IGF-1 concentrations were measured at the time of presentation (ie, day 0) and at days 3, 7, 14, and 28 after admission (if the patient remained hospitalized).

MAIN OUTCOMES AND MEASURES: Baseline hormone concentrations were compared among patients who had severe COVID-19 vs those with milder COVID-19 illness. RNA sequencing was performed on circulating mononuclear cells to understand the mechanistic association of altered circulating hormone concentrations with cellular signaling pathways.

RESULTS: Among 152 patients (90 [59.2%] men; 62 [40.8%] women; mean [SD] age, 63 [16] years), 143 patients (94.1%) were hospitalized. Among 66 men with severe COVID-19, median [interquartile range] testosterone concentrations were lower at day 0 (53 [18 to 114] ng/dL vs 151 [95 to 217] ng/dL; P = .01) and day 3 (19 [6 to 68] ng/dL vs 111 [49 to 274] ng/dL; P = .006) compared with 24 men with milder disease. Testosterone concentrations were inversely associated with concentrations of interleukin 6 (β = -0.43; 95% CI, -0.52 to -0.17; P < .001), C-reactive protein (β = -0.38; 95% CI, -0.78 to -0.16; P = .004), interleukin 1 receptor antagonist (β = -0.29; 95% CI, -0.64 to -0.06; P = .02), hepatocyte growth factor (β = -0.46; 95% CI, -0.69 to -0.25; P < .001), and interferon γ-inducible protein 10 (β = -0.32; 95% CI, -0.62 to -0.10; P = .007). Estradiol and IGF-1 concentrations were not associated with COVID-19 severity in men. Testosterone, estradiol, and IGF-1 concentrations were similar in women with and without severe COVID-19. Gene set enrichment analysis revealed upregulated hormone signaling pathways in CD14+CD16- (ie, classical) monocytes and CD14-CD16+ (ie, nonclassical) monocytes in male patients with COVID-19 who needed intensive care unit treatment vs those who did not.

CONCLUSIONS AND RELEVANCE: In this single-center cohort study of patients with COVID-19, lower testosterone concentrations during hospitalization were associated with increased disease severity and inflammation in men. Hormone signaling pathways in monocytes did not parallel serum hormone concentrations, and further investigation is required to understand their pathophysiologic association with COVID-19.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Dhindsa S, Zhang N, McPhaul MJ, et al. Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19. JAMA Netw Open. 2021. PMID: 34032853. doi:10.1001/jamanetworkopen.2021.11398

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。